Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France

Osteoporosis International

Volumn 28, Issue 3, 2017, Pages 833-840

  Hiligsmann, M ^a   Burlet, N ^b   Fardellone, P ^c   Al Daghri, N ^d   Reginster, J Y ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Cost effectiveness; Dairy products; Fractures; France; Public health

Indexed keywords

CALCIUM; VITAMIN D;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DAIRY PRODUCT; ECONOMIC EVALUATION; FEMALE; FRACTURE; FRANCE; HIP FRACTURE; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; AGE DISTRIBUTION; COST BENEFIT ANALYSIS; DIET THERAPY; ECONOMICS; FORTIFIED FOOD; FRAGILITY FRACTURE; INCIDENCE; MIDDLE AGED; OSTEOPOROSIS; PROCEDURES; PUBLIC HEALTH; VERY ELDERLY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; DAIRY PRODUCTS; FEMALE; FOOD, FORTIFIED; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PUBLIC HEALTH; QUALITY-ADJUSTED LIFE YEARS; VITAMIN D;

EID: 84991594220     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-016-3786-1     Document Type: Article

References (37)

1. Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA (2013) Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos 8:137. doi:10.1007/s11657-013-0137-0
2. Briot K, Maravic M, Roux C (2015) Changes in number and incidence of hip fractures over 12 years in France. Bone 81:131–137. doi:10.1016/j.bone.2015.07.009
3. Rizzoli R, Boonen S, Brandi ML, Bruyere O, Cooper C, Kanis JA, Kaufman JM, Ringe JD, Weryha G, Reginster JY (2013) Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 29(4):305–313. doi:10.1185/03007995.2013.766162
4. Bruyere O, De Cock C, Mottet C, Neuprez A, Malaise O, Reginster JY (2009) Low dietary calcium in European postmenopausal osteoporotic women. Public Health Nutr 12(1):111–114. doi:10.1017/S1368980008002024
5. Bruyere O, Slomian J, Beaudart C, Buckinx F, Cavalier E, Gillain S, Petermans J, Reginster JY (2014) Prevalence of vitamin D inadequacy in European women aged over 80 years. Arch Gerontol Geriatr 59(1):78–82. doi:10.1016/j.archger.2014.03.010
6. Fardellone P, Cotte FE, Roux C, Lespessailles E, Mercier F, Gaudin AF (2010) Calcium intake and the risk of osteoporosis and fractures in French women. Joint, bone, spine: revue du rhumatisme 77(2):154–158. doi:10.1016/j.jbspin.2009.08.007
7. De Cock C, Bruyere O, Collette J, Reginster JY (2008) Vitamin D inadequacy in French osteoporotic and osteopenic women. Joint, bone, spine: revue du rhumatisme 75(5):567–572. doi:10.1016/j.jbspin.2007.10.012
8. Dupuy C, Lauwers-Cances V, van Kan GA, Gillette S, Schott AM, Beauchet O, Annweiler C, Vellas B, Rolland Y (2013) Dietary vitamin D intake and muscle mass in older women: results from a cross-sectional analysis of the EPIDOS study. J Nutr Health Aging 17(2):119–124. doi:10.1007/s12603-012-0089-x
9. Czernichow S, Fan T, Nocea G, Sen SS (2010) Calcium and vitamin D intake by postmenopausal women with osteoporosis in France. Curr Med Res Opin 26(7):1667–1674. doi:10.1185/03007995.2010.483658
10. Mensink GB, Fletcher R, Gurinovic M, Huybrechts I, Lafay L, Serra-Majem L, Szponar L, Tetens I, Verkaik-Kloosterman J, Baka A, Stephen AM (2013) Mapping low intake of micronutrients across Europe. Br J Nutr 110(4):755–773. doi:10.1017/S000711451200565X
11. Rizzoli R, Boonen S, Brandi ML, Burlet N, Delmas P, Reginster JY (2008) The role of calcium and vitamin D in the management of osteoporosis. Bone 42(2):246–249. doi:10.1016/j.bone.2007.10.005
12. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for C, Economic Aspects of O, Osteoarthritis, the Committee of Scientific Advisors of the International Osteoporosis F (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24(1):23–57. doi:10.1007/s00198-012-2074-y
13. French National Nutrition and Health Program. 2015. Available from http://social-sante.gouv.fr/IMG/pdf/PNNS_UK_INDD_V2.pdf.
14. Ethgen O, Hiligsmann M, Burlet N, Reginster JY (2015) Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures. Arch Public Health 73:48. doi:10.1186/s13690-015-0099-3
15. Sandmann A, Amling M, Barvencik F, Konig HH, Bleibler F (2015) Economic evaluation of vitamin D and calcium food fortification for fracture prevention in Germany. Public Health Nutr:1–10. doi:10.1017/S1368980015003171
16. Lotters FJ, Lenoir-Wijnkoop I, Fardellone P, Rizzoli R, Rocher E, Poley MJ (2013) Dairy foods and osteoporosis: an example of assessing the health-economic impact of food products. Osteoporos Int 24(1):139–150. doi:10.1007/s00198-012-1998-6
17. Hiligsmann M, Ben Sedrine W, Bruyere O, Evers SM, Rabenda V, Reginster JY (2015) Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis. Eur J Pub Health 25(1):20–25. doi:10.1093/eurpub/cku119
18. Hiligsmann M, Ethgen O, Bruyere O, Richy F, Gathon HJ, Reginster JY (2009) Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value Health 12(5):687–696. doi:10.1111/j.1524-4733.2008.00497.x
19. Hiligsmann M, Reginster JY (2011) Cost effectiveness of denosumab compared with oral bisphosphonates in the treatment of post-menopausal osteoporotic women in Belgium. PharmacoEconomics 29(10):895–911. doi:10.2165/11539980-000000000-00000
20. INSEE, Estimations de population au 1er janvier 2015 en France métropolitaine (données provisoires arrêtées à fin 2014).
21. INSEE, Projections de population 2007–2060 en France Métropolitaine.
22. INSEE, Statistiques de l’état civil et estimations de population. Table de mortalité des années 2011–2013, données provisoires arrêtées à fin décembre 2014. N° 167 Société - avril 2015.
23. Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152(6):380–390. doi:10.7326/0003-4819-152-6-201003160-00008
24. Prigent A, Auraaen A, Kamendje-Tchokobou B, Durand-Zaleski I, Chevreul K (2014) Health-related quality of life and utility scores in people with mental disorders: a comparison with the non-mentally ill general population. Int J Environ Res Public Health 11(3):2804–2817. doi:10.3390/ijerph110302804
25. Hiligsmann M, Ethgen O, Richy F, Reginster JY (2008) Utility values associated with osteoporotic fracture: a systematic review of the literature. Calcif Tissue Int 82(4):288–292. doi:10.1007/s00223-008-9117-6
26. Bouee S, Lafuma A, Fagnani F, Meunier PJ, Reginster JY (2006) Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries. Rheumatol Int 26(12):1063–1072. doi:10.1007/s00296-006-0180-x
27. Cotte FE, De Pouvourville G (2011) Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France. BMC Health Serv Res 11:151. doi:10.1186/1472-6963-11-151
28. Melton LJ 3rd, Thamer M, Ray NF, Chan JK, Chesnut CH 3rd, Einhorn TA, Johnston CC, Raisz LG, Silverman SL, Siris ES (1997) Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 12(1):16–23. doi:10.1359/jbmr.1997.12.1.16
29. Drame M, Fierobe F, Lang PO, Jolly D, Boyer F, Mahmoudi R, Somme D, Laniece I, Heitz D, Gauvain JB, Voisin T, De Wazieres B, Gonthier R, Ankri J, Saint-Jean O, Couturier P, Jeandel C, Blanchard F, Novella JL (2011) Predictors of institution admission in the year following acute hospitalisation of elderly people. J Nutr Health Aging 15(5):399–403
30. Avenell A, Mak JC, O’Connell D (2014) Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 4:CD000227. doi:10.1002/14651858.CD000227.pub4
31. Ethgen O, Hiligsmann M, Burlet N, Reginster JY (2016) Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures. Osteoporos Int 27(1):301–308. doi:10.1007/s00198-015-3319-3
32. Kiely M, Black LJ (2012) Dietary strategies to maintain adequacy of circulating 25-hydroxyvitamin D concentrations. Scandinavian journal of clinical and laboratory investigation Supplementum 243:14–23. doi:10.3109/00365513.2012.681893
33. Calvo MS, Whiting SJ (2013) Survey of current vitamin D food fortification practices in the United States and Canada. J Steroid Biochem Mol Biol 136:211–213. doi:10.1016/j.jsbmb.2012.09.034
34. Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM (2007) Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 167(10):1050–1059. doi:10.1001/archinte.167.10.1050
35. Rizzoli R (2014) Dairy products, yogurts, and bone health. Am J Clin Nutr 99(5 Suppl):1256S–1262S. doi:10.3945/ajcn.113.073056
36. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1:CD007470. doi:10.1002/14651858.CD007470.pub3
37. Holick MF (2015) Vitamin D is not as toxic as was once thought: a historical and an up-to-date perspective. Mayo Clin Proc 90(5):561–564. doi:10.1016/j.mayocp.2015.03.015